Literature DB >> 1994082

Application of a new positioning device for isometric replacement in anterior cruciate ligament repair and reconstruction.

J Raunest1.   

Abstract

The functional effects of displacing the cruciate ligament attachments were studied in ten adult cadaver knees. On a systematic variation of the femoral and tibial attachment sites according to a three-dimensional raster scheme, a quantitative analysis of the absolute length and of motion-dependent changes in ligament isometry was performed. All insertion points deviating from the original anatomic landmarks did not accomplish biomechanical requirements. A femoral displacement had an increased effect on disturbing isometry compared to a tibial malposition. Although recommended by several authors, the "over-the-top" position gave the most unsatisfactory results with a maximum isometry failure of 10 mm. In cruciate ligament replacement a positioning guide with isometry testing capacity should be mandatory to ensure correct placement of bone tunnels. For this purpose a new positioning device which allows for isometry measurements before a bone channel is drilled is introduced and applied in an experimental setup.

Mesh:

Year:  1991        PMID: 1994082

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

1.  TriLink: Anatomic Double-Bundle Anterior Cruciate Ligament Reconstruction.

Authors:  Sam K Yasen; James S Logan; James O Smith; Tamara Nancoo; Mike J Risebury; Adrian J Wilson
Journal:  Arthrosc Tech       Date:  2013-11-28

2.  Graft isometricity in unitunnel anterior cruciate ligament reconstruction: analysis of influential factors using a radiographic model.

Authors:  J A Feller; R R Glisson; A V Seaber; J A Feagin; W E Garrett
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1993       Impact factor: 4.342

Review 3.  Review on tension in the natural and reconstructed anterior cruciate ligament.

Authors:  H N Andersen; A A Amis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1994       Impact factor: 4.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.